Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Will Use Genetix's ClonePixFL in PD-Direct Offering

NEW YORK (GenomeWeb News) - Invitrogen will use Genetix's ClonePixFL technology in its process-development services, the company said today.
 
The technology will be offered through Invitrogen's PD-Direct offering.
 
Invitrogen also said it will develop applications to integrate ClonePixFL with its Revolution technology.
 
The Genetix ClonePixFL automatically images and selects mammalian cell colonies based upon a set of parameters.
 
Financial details were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.